FinaleMe: Predicting DNA Methylation by the Fragmentation Patterns of Plasma Cell-free DNA
Overview
Authors
Affiliations
Analysis of DNA methylation in cell-free DNA reveals clinically relevant biomarkers but requires specialized protocols such as whole-genome bisulfite sequencing. Meanwhile, millions of cell-free DNA samples are being profiled by whole-genome sequencing. Here, we develop FinaleMe, a non-homogeneous Hidden Markov Model, to predict DNA methylation of cell-free DNA and, therefore, tissues-of-origin, directly from plasma whole-genome sequencing. We validate the performance with 80 pairs of deep and shallow-coverage whole-genome sequencing and whole-genome bisulfite sequencing data.
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.
Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V Nat Rev Cancer. 2025; .
PMID: 40038442 DOI: 10.1038/s41568-025-00795-x.
Fu H, Huang K, Zhu W, Zhang L, Bandaru R, Wang L medRxiv. 2025; .
PMID: 40034794 PMC: 11875267. DOI: 10.1101/2025.02.14.25322180.
Artificial intelligence and machine learning in cell-free-DNA-based diagnostics.
Tsui W, Ding S, Jiang P, Lo Y Genome Res. 2025; 35(1):1-19.
PMID: 39843210 PMC: 11789496. DOI: 10.1101/gr.278413.123.
Precise control of transmembrane current via regulating bionic lipid membrane composition.
Shang Z, Zhao J, Yang M, Xiao Y, Chu W, Xu S Sci Adv. 2024; 10(35):eadq0118.
PMID: 39213352 PMC: 11364097. DOI: 10.1126/sciadv.adq0118.
Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes.
Sirajee A, Kabiraj D, De S Transl Oncol. 2024; 49:102085.
PMID: 39178576 PMC: 11388671. DOI: 10.1016/j.tranon.2024.102085.